Dr. Vandigo is a health services researcher trained in continuous patient engagement who brings more than a decade of research and policy experience around health technology assessment in the United States.  He oversees work related to the policy and patient engagement methods in health technology assessment.

He joins Applied Patient Experience from the Market Access Innovation team at Novartis. His role there focused on developing value-based pricing approaches and highlighting pharmaceutical market distortions that impact patient access. Before Novartis, he spent five years at PhRMA, the trade organization representing innovative biopharmaceutical manufacturers. At PhRMA, his research highlighted gaps in existing methods of value assessment. His portfolio also included research and policy strategy development related to the impact of hospital consolidation and market power on pharmaceutical prices, innovative contracting approaches, and novel financing arrangements.

Prior to PhRMA, Dr. Vandigo engaged patients and educated researchers to build patient-centered outcomes research (PCOR) capacity in Baltimore as part of The PATIENTS Program at the University of Maryland School of Pharmacy.

Dr. Vandigo earned his PhD in Pharmaceutical Health Services Research at the University of Maryland School of Pharmacy, his MBA from the University of Louisiana at Monroe, and his BS in Finance from Southeastern Louisiana University.